Your browser doesn't support javascript.
loading
A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients.
García-Torralba, Esmeralda; Navarro Manzano, Esther; Luengo-Gil, Gines; De la Morena Barrio, Pilar; Chaves Benito, Asunción; Pérez-Ramos, Miguel; Álvarez-Abril, Beatriz; Ivars Rubio, Alejandra; García-Garre, Elisa; Ayala de la Peña, Francisco; García-Martínez, Elena.
Affiliation
  • García-Torralba E; Department of Haematology and Medical Oncology, University Hospital Morales Meseguer, Murcia, Spain.
  • Navarro Manzano E; Department of Medicine, Medical School, University of Murcia, Murcia, Spain.
  • Luengo-Gil G; Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
  • De la Morena Barrio P; Department of Medicine, Medical School, University of Murcia, Murcia, Spain.
  • Chaves Benito A; Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
  • Pérez-Ramos M; Department of Haematology and Medical Oncology, University Hospital Morales Meseguer, Murcia, Spain.
  • Álvarez-Abril B; Department of Medicine, Medical School, University of Murcia, Murcia, Spain.
  • Ivars Rubio A; Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
  • García-Garre E; Department of Haematology and Medical Oncology, University Hospital Morales Meseguer, Murcia, Spain.
  • Ayala de la Peña F; Department of Medicine, Medical School, University of Murcia, Murcia, Spain.
  • García-Martínez E; Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
Front Oncol ; 13: 1182725, 2023.
Article in En | MEDLINE | ID: mdl-37313470

Full text: 1 Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Year: 2023 Type: Article